Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced February 2015.
Novigenix SA acquired fellow private Swiss molecular diagnostics firm Diagnoplex SA, and now has full control of the Colox colorectal cancer diagnostic. (Feb.)
Details of the transaction were not released. Colox is a blood-based test that analyzes the expression of 29 different genes...